Arkolith/Insider Trading/DNTH/Form 4

Garcia Marino

CEO AND PRESIDENT, DirectorDianthus Therapeutics, Inc. /DE/ (DNTH) · full profile →Form 4 · filed Mar 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10.0M
Net Open-Market Flow
-$10.0M
Transactions
7
6 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 12, 2026Sell(S)66K$81.74$5.4M14K
Mar 12, 2026Sell(S)44K$80.69$3.5M79K
Mar 12, 2026Option exercise(M)123K$6.70$824K123K
Mar 12, 2026Sell(S)13K$82.60$1.1M1K
Mar 12, 2026Sell(S)200$83.38$17K900
Mar 12, 2026Sell(S)900$85.53$77K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 12, 2026Option exercise(M)123K—$060K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001669866-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML